Bahrain approves Oxford-AstraZeneca COVID-19 vaccine for emergency use

Published: Updated:

Bahrain has approved the Oxford-AstraZeneca COVID-19 vaccine for emergency use, state news agency BNA reported on Monday, citing the Gulf country’s National Health Regulatory Authority.

For more coronavirus news, visit our dedicated page.

Earlier this month, Bahrain’s King Hamad bin Isa al-Khalifa has taken the initiative to receive the COVID-19 vaccine, according to an official statement from the Bahrain News Agency.

“God has endowed Bahrain with a society with a high level of awareness and keenness to adhere to all precautionary measures and directives issued by the national medical taskforce to combat the coronavirus, which had a great impact on the Kingdom’s ability to limit its spread within the community,” the King said.

A January shipment of the Pfizer-BioNTech vaccine to the Gulf state of Bahrain will not arrive on time, the ministry of health said, but second doses of the jab already scheduled will not be affected.

In December 2020, Bahrain approved the use of a Chinese coronavirus vaccine, following its earlier approval of a vaccine made by Pfizer and its German partner BioNTech.

Read more:

Coronavirus: Bahrain’s King Hamad receives COVID-19 vaccine

Coronavirus: Pfizer delays Bahrain’s vaccine delivery for January